BioCentury | Jul 3, 2006
Finance

Ebb & Flow

...closed Friday at $6.93 . . . Ridgeback Capital owns 4.1 million shares (7.2%) and Tudor Investment...
BioCentury | Apr 25, 2005
Finance

Ebb & Flow

...its MIP-120T radiotherapeutic to treat neuroendocrine tumors. Investors in the round included Siemens Venture Capital; Tudor Investment...
BioCentury | Apr 22, 2005
Financial News

Molecular Insight raises $28 million

...C round led by Frederick Frank and Cerberus Capital. New investors included Siemens Venture Capital; Tudor Investment...
BioCentury | Dec 9, 1996
Finance

Wallflower

...have a $74 million market cap. The company is developing drugs for HIV and cancer. Tudor Investment...
Items per page:
1 - 4 of 4
BioCentury | Jul 3, 2006
Finance

Ebb & Flow

...closed Friday at $6.93 . . . Ridgeback Capital owns 4.1 million shares (7.2%) and Tudor Investment...
BioCentury | Apr 25, 2005
Finance

Ebb & Flow

...its MIP-120T radiotherapeutic to treat neuroendocrine tumors. Investors in the round included Siemens Venture Capital; Tudor Investment...
BioCentury | Apr 22, 2005
Financial News

Molecular Insight raises $28 million

...C round led by Frederick Frank and Cerberus Capital. New investors included Siemens Venture Capital; Tudor Investment...
BioCentury | Dec 9, 1996
Finance

Wallflower

...have a $74 million market cap. The company is developing drugs for HIV and cancer. Tudor Investment...
Items per page:
1 - 4 of 4